Cite
HARVARD Citation
Raghavan, S. et al. (n.d.). Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan. European journal of contraception & reproductive health care. pp. 104-111. [Online].